LUYE PHARMA GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.960 HKD | +0.34% |
|
0.00% | -20.64% |
| 08-30 | Citi Upgrades Luye Pharma to Buy From Sell; Price Target is HK$4 | MT |
| 08-28 | Luye Pharma Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
Evolution of the Average Target: Luye Pharma Group Ltd.
Evolution of the Target Price: Luye Pharma Group Ltd.
Changes in Analyst Recommendations: Luye Pharma Group Ltd.
6f505d6ec40cf799fb36e5be85bb35d9.P_9pZunmUO72f0Lfm6orNMvCF5Izyq3q6J3VQBJ1XnU.a7srCaaMO6jPCzbt8JJZZb_xSPlhreODmfOnDlgNPxsSxw4fiKckm445LQ~90ca3a75d22ae5726d8766271ba78036
| Analyst Opinion | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
|---|---|---|---|---|---|---|
| +21.12% | ||||||
| +9.85% | ||||||
| +7.10% | ||||||
| +2.55% | ||||||
| +1.47% | ||||||
| +17.53% | ||||||
| +13.11% | ||||||
| +16.47% | ||||||
| +0.67% | ||||||
| -2.43% | ||||||
| Average | +8.74% | |||||
| Weighted average by Cap. | +7.76% |
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2.695CNY
Average target price
3.275CNY
Spread / Average Target
+21.52%
High Price Target
3.641CNY
Spread / Highest target
+35.12%
Low Price Target
2.556CNY
Spread / Lowest Target
-5.15%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Citigroup |
Trading Rating
Investor Rating
ESG Refinitiv
B-
- Stock Market
- Equities
- 2186 Stock
- Consensus Luye Pharma Group Ltd.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition